{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:45:28Z","timestamp":1768311928701,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003786","name":"Hangzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["20191203B105"],"award-info":[{"award-number":["20191203B105"]}],"id":[{"id":"10.13039\/501100003786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003786","name":"Hangzhou Science and Technology Bureau","doi-asserted-by":"publisher","award":["20191203B96"],"award-info":[{"award-number":["20191203B96"]}],"id":[{"id":"10.13039\/501100003786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008856","name":"Zhejiang Provincial Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016114","name":"Zhejiang Medical Association","doi-asserted-by":"publisher","award":["2020ZYC-A13"],"award-info":[{"award-number":["2020ZYC-A13"]}],"id":[{"id":"10.13039\/501100016114","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2021KY890"],"award-info":[{"award-number":["2021KY890"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.clinre.2022.102063","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:34:30Z","timestamp":1670358870000},"page":"102063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Metabolic-associated fatty liver disease and the risk of cardiovascular disease"],"prefix":"10.1016","volume":"47","author":[{"given":"Pengwei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianhui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiake","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shenghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9060-5107","authenticated-orcid":false,"given":"Mingwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinre.2022.102063_bib0001","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.clinre.2022.102063_bib0002","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S2468-1253(22)00062-0","article-title":"Global multi-stakeholder consensus on the redefinition of fatty liver disease. Global multi-stakeholder endorsement of the MAFLD definition","volume":"7","author":"M\u00e9ndez-S\u00e1nchez","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.clinre.2022.102063_bib0003","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"International consensus panel. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinre.2022.102063_bib0004","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.clinre.2022.102063_bib0005","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"issue":"16","key":"10.1016\/j.clinre.2022.102063_bib0006","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.clinre.2022.102063_bib0007","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jhep.2020.12.016","article-title":"Clinical utility of the MAFLD definition","volume":"74","author":"Zheng","year":"2021","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.clinre.2022.102063_bib0008","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/hepr.13706","article-title":"MAFLD: renovation of clinical practice and disease awareness of fatty liver","volume":"52","author":"Kawaguchi","year":"2022","journal-title":"Hepatol Res"},{"issue":"9995","key":"10.1016\/j.clinre.2022.102063_bib0009","first-page":"743","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study","volume":"386","year":"2013","journal-title":"Lancet"},{"issue":"10290","key":"10.1016\/j.clinre.2022.102063_bib0010","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.clinre.2022.102063_bib0011","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/CIRCRESAHA.119.316337","article-title":"Nonalcoholic fatty liver disease pandemic fuels the upsurge in cardiovascular diseases","volume":"126","author":"Cai","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.clinre.2022.102063_bib0012","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00535-018-1516-5","article-title":"Clinical significance of hepatic steatosis according to coronary plaque morphology: assessment using controlled attenuation parameter","volume":"54","author":"Park","year":"2019","journal-title":"J Gastroenterol"},{"issue":"7","key":"10.1016\/j.clinre.2022.102063_bib0013","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41575-020-0316-6","article-title":"From NAFLD to MAFLD: when pathophysiology succeeds","volume":"17","author":"Tilg","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.clinre.2022.102063_bib0014","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.cgh.2021.05.029","article-title":"Differential clinical characteristics and mortality outcomes in persons With NAFLD and\/or MAFLD","volume":"19","author":"Nguyen","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.clinre.2022.102063_bib0015","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3350\/cmh.2021.0310","article-title":"MAFLD enhances clinical practice for liver disease in the Asia-Pacific region","volume":"28","author":"Kawaguchi","year":"2022","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.clinre.2022.102063_bib0016","unstructured":"National Center for Health Statistics, Centers for Disease Control and Prevention. The third National Health and Nutrition Examination Survey, NHANES III (1988-1994) https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/nhanes3\/default.aspx"},{"issue":"6","key":"10.1016\/j.clinre.2022.102063_bib0017","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.clinre.2022.102063_bib0018","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/hepr.13738","article-title":"Atherosclerotic cardiovascular disease in non-metabolic nonalcoholic fatty liver disease","volume":"52","author":"Tsutsumi","year":"2022","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clinre.2022.102063_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154433","article-title":"MAFLD and risk of CKD","volume":"115","author":"Sun","year":"2021","journal-title":"Metabolism"},{"issue":"6","key":"10.1016\/j.clinre.2022.102063_bib0020","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"APRICOT Clinical Investigators. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2022.102063_bib0021","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clinre.2022.102063_bib0022","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"issue":"19","key":"10.1016\/j.clinre.2022.102063_bib0023","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Treatment of high blood cholesterol in adults. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","author":"Detection","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.clinre.2022.102063_bib0024","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.clinre.2022.102063_bib0025","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2174\/1381612826666200128094231","article-title":"Causes of mortality in non-alcoholic fatty liver disease (NAFLD) and alcohol related fatty liver disease (AFLD)","volume":"26","author":"Johnston","year":"2020","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.clinre.2022.102063_bib0026","first-page":"2082","article-title":"Comparison of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","author":"Lin","year":"2020","journal-title":"Liver Int Offi J Int Assoc Study Liver"},{"issue":"3","key":"10.1016\/j.clinre.2022.102063_bib0027","doi-asserted-by":"crossref","first-page":"433","DOI":"10.5009\/gnl210167","article-title":"Innovative target exploration of NAFLD (ITEN) consortium. metabolic dysfunction-associated fatty liver disease predicts long-term mortality and cardiovascular disease","volume":"16","author":"Moon","year":"2022","journal-title":"Gut Liver"},{"issue":"11","key":"10.1016\/j.clinre.2022.102063_bib0028","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.clinre.2022.102063_bib0029","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1111\/jgh.15589","article-title":"Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease","volume":"36","author":"Tamaki","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2022.102063_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metab"},{"issue":"12","key":"10.1016\/j.clinre.2022.102063_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003410","article-title":"Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: a multivariable Mendelian randomization study","volume":"17","author":"Rosoff","year":"2020","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.clinre.2022.102063_bib0032","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.gastro.2015.09.007","article-title":"Hepatitis C virus infection is associated with increased cardiovascular mortality: a meta-analysis of observational studies","volume":"150","author":"Petta","year":"2016","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.clinre.2022.102063_bib0033","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jacc.2017.07.001","article-title":"Primary prevention of cardiovascular disease in diabetes mellitus","volume":"70","author":"Newman","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinre.2022.102063_bib0034","article-title":"The beneficial impact of metabolic dysfunction-associated fatty liver disease on lenvatinib treatment in patients with non-viral hepatocellular carcinoma","author":"Shimose","year":"2022","journal-title":"Hepatol Res"},{"issue":"8","key":"10.1016\/j.clinre.2022.102063_bib0035","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/hepr.13795","article-title":"Lean\/normal-weight metabolic dysfunction-associated fatty liver disease is a risk factor for reflux esophagitis","volume":"52","author":"Fukunaga","year":"2022","journal-title":"Hepatol Res"},{"issue":"1","key":"10.1016\/j.clinre.2022.102063_bib0036","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13098-022-00887-w","article-title":"MAFLD associated with COPD via systemic inflammation independent of aging and smoking in men","volume":"14","author":"Tsutsumi","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.clinre.2022.102063_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.711484","article-title":"Nonalcoholic fatty liver disease, liver fibrosis and cardiovascular disease in the Adult US Population","volume":"12","author":"Ciardullo","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.clinre.2022.102063_bib0038","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jhep.2021.07.035","article-title":"Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States","volume":"75","author":"Kim","year":"2021","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.clinre.2022.102063_bib0039","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/MEG.0000000000000286","article-title":"Association between liver fibrosis and coronary heart disease risk in patients with nonalcoholic fatty liver disease","volume":"27","author":"Dogan","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2022.102063_bib0040","doi-asserted-by":"crossref","first-page":"18323","DOI":"10.1038\/s41598-020-75266-4","article-title":"Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clinre.2022.102063_bib0041","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.hbpd.2018.01.007","article-title":"Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: either non-obese or obese Chinese population","volume":"17","author":"Lee","year":"2018","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"11","key":"10.1016\/j.clinre.2022.102063_bib0042","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/hepr.13685","article-title":"MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: generalized estimating equation approach","volume":"51","author":"Tsutsumi","year":"2021","journal-title":"Hepatol Res"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740122001966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740122001966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:33:47Z","timestamp":1761896027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740122001966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2210740122001966"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2022.102063","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic-associated fatty liver disease and the risk of cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2022.102063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102063"}}